sparfloxacin has been researched along with Infections, Mycobacterium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, N; Arakawa, M; Usuda, Y; Wada, K; Yoshikawa, H | 1 |
| Kamisaka, K; Kawahara, S; Kibata, M; Mishima, Y; Nagare, H; Okada, C; Soda, R; Tada, A; Takahashi, K; Takeuchi, M | 1 |
| Bollet, C; de Lamballerie, X; de Micco, P; Gevaudan, MJ; Mallet, MN; Sambuc, R | 1 |
1 trial(s) available for sparfloxacin and Infections, Mycobacterium
| Article | Year |
|---|---|
[A trial of clinical application of sparfloxacin for treating mycobacterial infections].
Topics: Aged; Aged, 80 and over; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium Infections; Quinolones | 1995 |
2 other study(ies) available for sparfloxacin and Infections, Mycobacterium
| Article | Year |
|---|---|
[Therapeutic potential of sparfloxacin for preventing mycobacterial infections].
Topics: Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycobacterium Infections; Quinolones | 1994 |
[Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Mycobacterium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Opportunistic Infections; Quinolones; Rifabutin; Rifamycins | 1992 |